Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Gp IV Llc Orbimed currently holds 9,272,225 shares of Audentes Therapeutics, Inc. (BOLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Gp IV Llc Orbimed has been a net seller of BOLD stock. They have purchased $21.3M and sold $137.8M worth of shares.
Capital Gp IV Llc Orbimed's most recent insider trade was on Aug 7, 2019, when they sold 492,364 shares at $17.90 per share.
Capital Gp IV Llc Orbimed serves as Executive at Audentes Therapeutics, Inc. (BOLD). They have executed 54 insider transactions totaling $159.1M over their tenure at the company.
Capital Gp IV Llc Orbimed holds the position of Executive at Audentes Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Capital Gp IV Llc Orbimed has shown a selling trading pattern, with $21.3M in total purchases and $137.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Capital Gp IV Llc Orbimed was on Jun 22, 2018, when they sold $185.5M worth of ARMO shares. This transaction involved 3,709,356 shares at $50.00 per share.
Capital Gp IV Llc Orbimed currently owns 9,272,225 shares of Audentes Therapeutics, Inc. (BOLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Gp IV Llc Orbimed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Gp IV Llc Orbimed has 54 Form 4 filings on record as an insider at Audentes Therapeutics, Inc..
Set alerts for Capital Gp IV Llc Orbimed and 40,000+ other insiders.